...
首页> 外文期刊>Journal of Bioactive and Compatible Polymers >Preparation and evaluation of PCLA2575 membranes loaded ornidazole in vitro
【24h】

Preparation and evaluation of PCLA2575 membranes loaded ornidazole in vitro

机译:PCLA2575膜的制备与评价含有镁咪唑的体外葡唑

获取原文
获取原文并翻译 | 示例

摘要

The aim of this study was to evaluate the properties of the sustained release and antibacterial activity of the ornidazole-drug-loaded membranes using poly[(ethylene glycol)-caprolactone-lactide] (PCLA2575) as membrane material. Ornidazole-loaded membranes were prepared by solvent casting method with the proportion of 5wt%, 8wt%, and 10wt%, respectively. In vitro drug release properties were determined by ultraviolet spectrophotometric method. The antibacterial activities against Streptococcus mutans and Fusobacterium nucleatumin vitro were observed on solid culture medium. The membrane had the high drug loadings and slow-release performance. Drug release time was shortened with the increase in the content of ornidazole, but all of them can achieve more than 7days. The membrane had strong inhibitory effect on both S. mutans and F. nucleatum. As drug content increased, the antibacterial activities also increased. The membrane had better inhibitory effect on F. nucleatum than S. mutans. Therefore, the ornidazole drug-loaded membrane is expected to be used for the treatment of periodontal disease because of the obvious effect of periodontal pathogens inhibition and good sustained-release performance.
机译:本研究的目的是评估以聚[(乙二醇)-己内酯-丙交酯](PCLA2575)为膜材料的奥硝唑载药膜的缓释性能和抗菌活性。采用溶剂浇铸法制备了奥硝唑负载膜,其质量分数分别为5wt%、8wt%和10wt%。紫外分光光度法测定药物的体外释放特性。在固体培养基上观察了其对变形链球菌和核梭杆菌的体外抗菌活性。该膜具有高载药量和缓释性能。随着奥硝唑含量的增加,药物释放时间缩短,但均能达到7天以上。该膜对变形链球菌和有核分枝杆菌均有较强的抑制作用。随着药物含量的增加,抗菌活性也增加。该膜对变形链球菌的抑制效果优于有核链球菌。因此,奥硝唑载药膜具有明显的牙周致病菌抑制作用和良好的缓释性能,有望用于牙周病的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号